Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(13)
DRUG(3)
DIETARY_SUPPLEMENT(1)
RADIATION(1)
paclitaxel
3 trials
phase_1phase_2
susanne-arnold
Carboplatin
2 trials
phase_2
susanne-arnold
radiation
2 trials
phase_1
susanne-arnold
Radiotherapy
2 trials
phase_2
susanne-arnold
XRT
1 trial
phase_2
susanne-arnold
Artemesia annua
1 trial
phase_2
susanne-arnold
AR-67 (formerly DB-67)
1 trial
phase_1
arno-therapeutics
Ivermectin
1 trial
phase_2
susanne-arnold

+5 more interventions

13 unique interventions4 categories

Analytics

Trial Phases

Phase 13
Phase 24

Trial Status

Completed3
Terminated3
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT04374019Phase 2Terminated
Novel Agents for Treatment of High-risk COVID-19 Positive Patients
COVIDSars-CoV2
PrincipalinvestigatorStart date: 2020-05-01
NCT02994069Phase 2Active Not Recruiting
Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers
Carcinoma, Squamous CellHead and Neck Cancer
PrincipalinvestigatorStart date: 2017-04-11
NCT00176241Phase 1Terminated
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
Head and Neck Cancer
Principalinvestigator
NCT00176254Phase 2Completed
Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
Squamous Cell Carcinoma
Principalinvestigator
NCT00176267Phase 2Completed
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
Squamous Cell Carcinoma
Principalinvestigator
NCT00378404Phase 1Terminated
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
Non-Small Cell Lung Cancer
Principalinvestigator
NCT00389480Phase 1Completed
Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
Tumors
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Carcinoma, Squamous Cell3Cancer of Head and Neck2COVID1Carcinoma, Non-Small-Cell Lung1SARS-CoV-21Neoplasms1

Affiliations

University of Kentucky

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVIDSARS-CoV-2Carcinoma, Squamous Cell
Similarity Score15%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Non-Small-Cell LungCarcinoma, Squamous Cell
Similarity Score15%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

NeoplasmsCarcinoma, Non-Small-Cell Lung
Similarity Score10%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNeoplasms

Worked with same sponsors:

Bristol-Myers SquibbEli Lilly and Company
Similarity Score10%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

NeoplasmsCarcinoma, Non-Small-Cell Lung
Similarity Score10%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of Head and Neck
Similarity Score10%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Squamous Cell
Similarity Score10%

Puma

Biotechnology

Related
26 trials

Shared therapeutic areas:

NeoplasmsCarcinoma, Non-Small-Cell Lung
Similarity Score10%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Non-Small-Cell Lung
Similarity Score10%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNeoplasms
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT04374019Phase 2PrincipalInvestigator

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

COVIDSars-CoV2
Terminated
NCT02994069Phase 2PrincipalInvestigator

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

Carcinoma, Squamous CellHead and Neck Cancer
Active Not Recruiting
NCT00176241Phase 1PrincipalInvestigator

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

Head and Neck Cancer
Terminated
NCT00176254Phase 2PrincipalInvestigator

Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer

Squamous Cell Carcinoma
Completed
NCT00176267Phase 2PrincipalInvestigator

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

Squamous Cell Carcinoma
Completed
NCT00378404Phase 1PrincipalInvestigator

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

Non-Small Cell Lung Cancer
Terminated
NCT00389480Phase 1PrincipalInvestigator

Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies

Tumors
Completed

All 7 trials loaded